A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update

Eur Urol Focus. 2018 Apr;4(3):336-337. doi: 10.1016/j.euf.2018.07.011. Epub 2018 Jul 17.

Abstract

Preliminary results from our study provide further evidence that low-intensity extracorporeal shockwave therapy is a safe and effective treatment modality for erectile dysfunction. Our treatment protocol with shockwaves given to men over 2 wk had the most robust effect.

Trial registration: ClinicalTrials.gov NCT03067987.

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Clinical Protocols
  • Erectile Dysfunction / epidemiology
  • Erectile Dysfunction / psychology
  • Erectile Dysfunction / therapy*
  • Extracorporeal Shockwave Therapy / methods*
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Middle Aged
  • Testosterone / blood*
  • Treatment Outcome

Substances

  • Testosterone

Associated data

  • ClinicalTrials.gov/NCT03067987